Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity Investment Grade Securitized ETF
FSEC
|
+$3.85B |
| 2 |
Amazon
AMZN
|
+$2.42B |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$1.98B |
| 4 |
Gilead Sciences
GILD
|
+$1.88B |
| 5 |
lululemon athletica
LULU
|
+$1.87B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$4.94B |
| 2 |
Apple
AAPL
|
+$3.14B |
| 3 |
UnitedHealth
UNH
|
+$3.02B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.36B |
| 5 |
Salesforce
CRM
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.87% |
| 2 | Financials | 13.64% |
| 3 | Communication Services | 11.76% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Healthcare | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Brookfield Renewable
BEPC
$6.61B
| $24M | ﹤0.01% |
858,075
-2,421,029
| -74% | -$66.4M |
|
|
NEE.PRS
1602
NextEra Energy 7.299% Corporate Units
NEE.PRS
$2.12B
| $23.9M | ﹤0.01% |
496,700
| – | – |
|
1603
Teleflex
TFX
$5.8B
| $23.7M | ﹤0.01% |
171,831
+46,224
| +37% | +$7.49M |
|
1604
Boston Properties
BXP
$10.9B
| $23.7M | ﹤0.01% |
353,253
-380,806
| -52% | -$26.7M |
|
1605
DaVita
DVA
$11.6B
| $23.7M | ﹤0.01% |
155,068
-15,233
| -9% | -$2.39M |
|
1606
Zimmer Biomet
ZBH
$19.1B
| $23.3M | ﹤0.01% |
206,078
-1,231,933
| -86% | -$132M |
|
1607
LXP Industrial Trust 6.5% Series C Preferred Stock
LXP.PRC
$94.9M
| $23.2M | ﹤0.01% |
508,121
| – | – |
|
1608
TPG
TPG
$8.55B
| $23.1M | ﹤0.01% |
487,773
+29,849
| +7% | +$1.74M |
|
1609
Protagonist Therapeutics
PTGX
$9.92B
| $23.1M | ﹤0.01% |
478,343
+35,827
| +8% | +$1.5M |
|
1610
Plumas Bancorp
PLBC
$436M
| $22.9M | ﹤0.01% |
530,057
-25
| -0% | -$1.12K |
|
|
HOLX
1611
DELISTED
Hologic
HOLX
| $22.8M | ﹤0.01% |
368,520
-5,206,873
| -93% | -$345M |
|
1612
Broadridge
BR
$19.5B
| $22.6M | ﹤0.01% |
93,079
+7,754
| +9% | +$1.82M |
|
|
KRMN
1613
Karman Holdings
KRMN
$8.25B
| $22.5M | ﹤0.01% |
+674,693
| New | +$21.8M |
|
|
ZBIO
1614
Zenas BioPharma
ZBIO
$1.89B
| $22.5M | ﹤0.01% |
2,852,371
+1,070,656
| +60% | +$8.38M |
|
1615
Alliance Resource Partners
ARLP
$3.23B
| $22.5M | ﹤0.01% |
825,390
+151,800
| +23% | +$4.05M |
|
1616
Dollar General
DG
$27.3B
| $22.3M | ﹤0.01% |
254,021
+125,532
| +98% | +$9.5M |
|
1617
Iridium Communications
IRDM
$5.3B
| $22.2M | ﹤0.01% |
812,490
-29,848
| -4% | -$875K |
|
1618
Newmark Group
NMRK
$2.74B
| $22.2M | ﹤0.01% |
1,820,900
-2,026,647
| -53% | -$27M |
|
1619
Ericsson
ERIC
$33.6B
| $22.2M | ﹤0.01% |
2,855,039
-574,163
| -17% | -$4.64M |
|
1620
RingCentral
RNG
$5.4B
| $22.1M | ﹤0.01% |
893,150
+162,695
| +22% | +$5.07M |
|
1621
Organon & Co
OGN
$3.6B
| $22M | ﹤0.01% |
1,480,330
-147,713
| -9% | -$2.27M |
|
1622
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.33B
| $21.8M | ﹤0.01% |
546,830
-12,106
| -2% | -$479K |
|
1623
Taysha Gene Therapies
TSHA
$1.85B
| $21.7M | ﹤0.01% |
15,631,954
-733,710
| -4% | -$1.23M |
|
|
XOMA
1624
DELISTED
Xoma
XOMA
| $21.7M | ﹤0.01% |
1,088,370
-1,678
| -0.2% | -$40.4K |
|
1625
Monte Rosa Therapeutics
GLUE
$1.34B
| $21.7M | ﹤0.01% |
4,674,108
-874,340
| -16% | -$5.36M |
|
Similar funds
Fidelity Investments's Q1 2025 Portfolio in Review
As of Q1 2025, Fidelity Investments held 5,812 positions worth $1.57T, down 6.5% from $1.68T the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Fidelity Investments's Q1 2025 filing shows 268 new, 2,556 increased, 2,026 reduced and 507 closed positions. Its largest new stake was CoreWeave: 31,372,162 shares worth $1.17B. The largest sale was Alphabet (Google) Class A, an estimated $4.94B.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 31% a quarter earlier, followed by Financials and Communication Services.
- Fidelity Investments's largest Q1 2025 buy was CoreWeave: 31,372,162 shares worth $1.17B.
- Fidelity Investments added most to Fidelity Investment Grade Securitized ETF in Q1 2025, an estimated $3.85B increase.
- Fidelity Investments's biggest Q1 2025 reduction was Alphabet (Google) Class A, cutting an estimated $4.94B.
- Fidelity Investments fully exited Arch Resources, Inc. in Q1 2025, selling an estimated $301M.
- Fidelity Investments's ten largest holdings make up 33% of its $1.57T portfolio in Q1 2025.
- Fidelity Investments opened 268 new positions and closed 507 in Q1 2025.
- Fidelity Investments's portfolio value fell 6.5% quarter-over-quarter to $1.57T.
Based on Fidelity Investments's 13F filing for Q1 2025, filed 12 May 2025.